Education
About Us
Working with TipRanks
Follow Us
Conmed Corporation (CNMD)
:CNMD
Total Valuation
Conmed has a market cap or net worth of $1.50B. The enterprise value is $3.05B.
Market Cap$1.50B
Enterprise Value$3.05B
Share Statistics
Conmed has 30.93M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30.93M
Owned by Insiders0.67%
Owned by Instutions0.93%
Financial Efficiency
Conmed’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 8.02%.
Return on Equity (ROE)13.76%
Return on Assets (ROA)5.74%
Return on Invested Capital (ROIC)8.02%
Return on Capital Employed (ROCE)9.88%
Revenue Per Employee$334,621.795
Profits Per Employee$33,954.872
Employee Count3,900
Asset Turnover0.57
Inventory Turnover1.66
Valuation Ratios
The current PE Ratio of Conmed is 15.94. Conmed’s PEG ratio is 0.15.
PE Ratio15.94
PS Ratio1.62
PB Ratio2.19
Price to Fair Value2.19
Price to FCF13.72
Price to Operating Cash Flow12.64
PEG Ratio0.15
Income Statement
In the last 12 months, Conmed had revenue of $1.31B and earned $132.42M in profits. Earnings per share was $4.29.
Revenue$1.31B
Gross Profit$712.47M
Operating Income$197.71M
Pretax Income$163.03M
Net Income$132.42M
EBITDA256.23M
Earnings Per Share (EPS)4.29
Cash Flow
In the last 12 months, operating cash flow was $166.97M and capital expenditures -$13.08M, giving a free cash flow of $153.88M billion.
Operating Cash Flow$166.97M
Free Cash Flow$153.88M
Free Cash Flow per Share$4.98
Dividends & Yields
Conmed pays an annual dividend of $0.80, resulting in a dividend yield of 1.67%
Dividend Per Share$0.80
Dividend Yield1.67%
Payout Ratio19.23%
Free Cash Flow Yield7.29%
Earnings Yield6.27%
Stock Price Statistics
Beta0.37
52-Week Price Change-30.83%
50-Day Moving Average59.16
200-Day Moving Average67.00
Relative Strength Index (RSI)32.21
Average Volume (3m)536.10K
Important Dates
Conmed upcoming earnings date is Apr 30, 2025, After Close.
Last Earnings DateFeb 5, 2025
Next Earnings DateApr 30, 2025
Ex-Dividend DateMar 14, 2025
Financial Position
Conmed as a current ratio of 2.30, with Debt / Equity ratio of 0.94
Current Ratio2.30
Quick Ratio1.05
Debt to Market Cap0.43
Net Debt to EBITDA3.24
Interest Coverage Ratio5.37
Taxes
In the past 12 months, Conmed has paid $30.61M in taxes.
Income Tax$30.61M
Effective Tax Rate18.77%
Enterprise Valuation
Conmed EV to EBITDA ratio is 10.99, with an EV/FCF ratio of 19.45.
EV to Sales2.29
EV to EBITDA10.99
EV to Free Cash Flow19.45
EV to Operating Cash Flow17.92
Balance Sheet
Conmed has $24.46M in cash and marketable securities with $905.78M in debt, giving a net cash position of $881.32M billion.
Cash & Marketable Securities$24.46M
Total Debt$905.78M
Net Cash$881.32M
Net Cash Per Share$28.49
Tangible Book Value Per Share-$14.92
Margins
Gross margin is 56.08%, with operating margin of 15.33%, and net profit margin of 10.13%.
Gross Margin56.08%
Operating Margin15.33%
Pretax Margin12.47%
Net Profit Margin10.13%
EBITDA Margin20.82%
EBIT Margin15.33%
Analyst Forecast
The average price target for Conmed is $77.17, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$77.17
Price Target Upside58.82%
Analyst ConsensusModerate Buy
Analyst Count6
Revenue Growth Forecast4.98%
EPS Growth Forecast104.60%